These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1830354)

  • 1. [Clarithromycin in the treatment of respiratory infections].
    Med Clin (Barc); 1991 Jun; 97(1):suppl 2 p.. PubMed ID: 1830354
    [No Abstract]   [Full Text] [Related]  

  • 2. New macrolide antibiotics: clarithromycin and azithromycin.
    Stott GA
    Am Fam Physician; 1992 Sep; 46(3):863-9. PubMed ID: 1325106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twice daily dosing of erythromycin acistrate in the treatment of acute bronchitis and pneumonia.
    Wiesner B; Wilen-Rosenqvist G; Lehtonen L
    Arzneimittelforschung; 1993 Sep; 43(9):1014-7. PubMed ID: 8240450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of Clarithromycin in the treatment of acute mild to moderate respiratory tract infections.
    O'Neill SJ; Millar ED; Coles SJ; Bachand RT
    Ir Med J; 1991 Mar; 84(1):33-5. PubMed ID: 1828461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The new macrolactones: clarithromycin (Biaxin) and azithromycin (Zithromax).
    Peltier K
    Conn Med; 1992 Jul; 56(7):371-4. PubMed ID: 1330429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clarithromycin in the treatment of community-acquired lower respiratory tract infections.
    Anderson G
    J Hosp Infect; 1991 Sep; 19 Suppl A():21-7. PubMed ID: 1684979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clarithromyocin new approaches to the treatment of respiratory tract infection. Seventh Mediterranean Congress of Chemotherapy. Barcelona, Spain, May 1990.
    J Antimicrob Chemother; 1991 Feb; 27 Suppl A():1-124. PubMed ID: 1827093
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical efficacy of clarithromycin].
    Med Clin (Barc); 1991 Sep; 97(7):suppl 2 p.. PubMed ID: 1834897
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of spiramycin and clarithromycin for community-acquired lower respiratory tract infections.
    Rocha RT; Awad CE; Ali A; Matyas R; Vital AC; Silva CO; Dainesi SM; Salazar MS; Nakatani J
    Int J Clin Pract; 1999 Sep; 53(6):433-6. PubMed ID: 10622070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clarithromycin in the treatment of bacterial relapses of chronic bronchitis.
    Dericoloso A; Sanduzzi A; Cuccurullo S; Sarno M; Bianco A; Moro RA
    Riv Eur Sci Med Farmacol; 1991; 13(5-6):275-83. PubMed ID: 1840282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clarithromycin, a unique macrolide. A pharmacokinetic, microbiological, and clinical overview.
    Hardy DJ; Guay DR; Jones RN
    Diagn Microbiol Infect Dis; 1992 Jan; 15(1):39-53. PubMed ID: 1530914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical observations with clarithromycin in pediatrics].
    Sekiguchi T; Okamoto T; Ohara K; Nishimori M; Kozan S; Miyazaki M
    Jpn J Antibiot; 1989 Feb; 42(2):411-9. PubMed ID: 2526254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Meta-analysis of clarithromycin compared to other antibiotics for the treatment of lower respiratory tract infections].
    Gálvez-Múgica MA; Espinosa de los Monteros MJ; Gallego Sandín S; Novalbos J; Abad-Santos F
    Rev Esp Quimioter; 2003 Dec; 16(4):403-11. PubMed ID: 14961134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telithromycin: new preparation. A needless addition to the other macrolides.
    Prescrire Int; 2003 Feb; 12(63):8-11. PubMed ID: 12602373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical experience with clarithromycin in the pediatric field].
    Tayama M; Ichioka T; Hosoda T; Miyao M
    Jpn J Antibiot; 1989 Feb; 42(2):388-92. PubMed ID: 2526251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clarithromycin versus cefaclor in lower respiratory tract infections. The Canadian Bronchitis Study Group.
    Fong IW; Laforge J; Dubois J; Small D; Grossman R; Zakhari R
    Clin Invest Med; 1995 Apr; 18(2):131-8. PubMed ID: 7788958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ofloxacin in community-acquired lower respiratory infections. A comparison with amoxicillin or erythromycin.
    Stocks JM; Wallace RJ; Griffith DE; Garcia JG; Kohler RB
    Am J Med; 1989 Dec; 87(6C):52S-56S. PubMed ID: 2690620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience with clarithromycin in pediatric patients].
    Iguchi K; Kawaguchi H; Kamiya H; Sakurai M
    Jpn J Antibiot; 1989 Feb; 42(2):339-42. PubMed ID: 2526246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of flurythromycin ethylsuccinate in infections of lower airways due to sensitive germs: multicenter comparative study with clarithromycin.
    Vagliasindi M
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):245-9. PubMed ID: 9208340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a new erythromycin product--eryc--in the treatment of the lower respiratory tract infections.
    Adám A; Kuberka Z
    Ther Hung; 1990; 38(4):152-5. PubMed ID: 2094053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.